• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY MITEK LLC US TACIT QA #2/0 ETH V5; SOFT-TISSUE ANCHOR, NON-BIOABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY MITEK LLC US TACIT QA #2/0 ETH V5; SOFT-TISSUE ANCHOR, NON-BIOABSORBABLE Back to Search Results
Model Number 212036
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/10/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product complaint #: (b)(4).Udi: (b)(4).
 
Event or Problem Description
It was reported by affiliate via email that during the procedure the suture and anchor were broken.No patient consequences or surgical delay reported.The device is available to be returned for evaluation.
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Additional information: b5: subsequent follow-up with the customer, additional information was received.It was reported that mini-anchors surgery was performed.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.H10 additional narrative: investigation summary
=
> according to the information provided, it was reported that during the procedure the suture and anchor were broken.The complaint device was received and evaluated.The anchor was reviewed under magnification, the anchor revealed no structural anomalies, besides the suture was found frayed or cuted.In addition, the handle and the thread drill also were received, as result the handle was found broken.This complaint can be confirmed.The possible root cause for the detached anchor can be attributed to the low tension applied in the suture for ruptured suture can be attributed to excessive force while inserting the anchor beyond its intended use causing it to bend and suture to snap.However, this cannot be conclusive determined.A manufacturing record evaluation was performed for the finished device [2l06363] number, and no non-conformances were identified.At this point in time, no corrective action is required and no further action is warranted.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.Udi: (b)(4).
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.H10 additional narrative: d10, h3, h6: the actual device has been returned and is currently pending evaluation.Once reliability engineering evaluates the device, a supplemental medwatch report will be sent accordingly.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACIT QA #2/0 ETH V5
Common Device Name
SOFT-TISSUE ANCHOR, NON-BIOABSORBABLE
Manufacturer (Section D)
DEPUY MITEK LLC US
325 paramount drive
raynham MA 02767
MDR Report Key9747887
Report Number1221934-2020-00670
Device Sequence Number16597961
Product Code MBI
UDI-Device Identifier10886705001842
UDI-Public10886705001842
Combination Product (Y/N)N
Initial Reporter CountryCO
PMA/510(K) Number
K961094
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,distri
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 02/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2023
Device Model Number212036
Device Catalogue Number212036
Device Lot Number2L06363
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/07/2020
Initial Date Received by Manufacturer 02/10/2020
Supplement Date Received by Manufacturer03/06/2020
04/07/2020
04/29/2020
Initial Report FDA Received Date02/24/2020
Supplement Report FDA Received Date03/06/2020
04/08/2020
04/30/2020
Patient Sequence Number1
Patient Weight82
-
-